BDO Wealth Advisors’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
Other funds holding NTLA
AIM
NAMA
AVAI
BDO Wealth Advisors's NTLA Position: Q2 2019 in Review
BDO Wealth Advisors sold out of Intellia Therapeutics (NTLA) in Q2 2019, closing a stake of 26 shares.
BDO Wealth Advisors first reported a position in NTLA in Q2 2018 and held it in 4 quarters. The position peaked at $1K in Q3 2018. 144 funds tracked by Wall St. Rank hold NTLA as of Q2 2019.
- BDO Wealth Advisors reported no remaining Intellia Therapeutics position as of Q2 2019 after selling out during the quarter.
- BDO Wealth Advisors sold 26 Intellia Therapeutics shares in Q2 2019.
- BDO Wealth Advisors first reported a position in Intellia Therapeutics in Q2 2018 and held it in 4 quarters.
- BDO Wealth Advisors's Intellia Therapeutics position peaked at $1K in Q3 2018.
- 144 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q2 2019.
Based on BDO Wealth Advisors's 13F filing for Q2 2019, filed 9 Aug 2019.